Piramal Critical Care said it has partnered with US-based pharmaceutical outsourcing facility Medivant Healthcare to address severe shortage of injectable drugs in hospitals across the United States. Through this partnership, the company and Medivant Healthcare will work together to distribute single-dose injectable drugs in approved states for COVID-19 patients that have fallen dangerously short in supply, Piramal Critical Care said in a statement.
Piramal Critical Care partners with Medivant Healthcare to supply injectable drugs in US
Date posted: Thursday 23 July 2020